Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2010 | 10-2009 | 10-2008 | 10-2007 | 10-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28 | 179 | 177 | 116 | 15 |
| Receivables | 57 | 41 | 43 | 6 | 18 |
| Inventories | 33 | 52 | 52 | 27 | 5 |
| TOTAL | $136 | $273 | $277 | $160 | $54 |
| Non-Current Assets | |||||
| PPE Net | 1 | 17 | 21 | 27 | 35 |
| TOTAL | $1 | $17 | $21 | $27 | $35 |
| Total Assets | $136 | $289 | $298 | $187 | $88 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 230 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 24 | 66 | 9 | 43 | 8 |
| Other current liabilities | N/A | N/A | N/A | 284 | 137 |
| TOTAL | $28 | $299 | $9 | $327 | $145 |
| Non-Current Liabilities | |||||
| Long Term Debt | 243 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 229 | 0 | 0 |
| TOTAL | $243 | $0 | $229 | $N/A | $N/A |
| Total Liabilities | $271 | $299 | $239 | $327 | $145 |
| Shareholders' Equity | |||||
| Retained earnings | -3,073 | -2,913 | -2,844 | -2,820 | -2,636 |
| TOTAL | $-135 | $-9 | $60 | $-140 | $-56 |
| Total Liabilities And Equity | $136 | $289 | $298 | $187 | $88 |